Formulation Development

Pharmaceutical formulation development is the critical step which links the discovery of a novel drug to commercialization. During this step, formulation scientists will determine the best drug delivery vehicle and dosage form needed to deliver a therapeutic effect based on bioavailability or other factors. Below you can explore articles, industry trends, and curated products which can help increase formulation development efficiency.

The Critical Role of Diagnostics in Antimicrobial Stewardship
Antimicrobial resistance (AMR) is a pressing global health challenge. While much of the discussion is focused on future implications, resistant infections are already having a profound impact. In 2019, bacterial AMR was directly responsible for an estimated 1.27 million deaths worldwide - more than HIV/AIDs or malaria.. The actions we take today ... read more
COVID-19 Five Years Later: The Impact on Drug Discovery
Five years ago, COVID-19 was declared a global pandemic, marking the official onset of a healthcare crisis that has claimed more than seven million lives and whose impact continues to resonate today. Initial containment efforts for the evasive and evolving SARS-CoV-2 virus required unprecedented collaboration between nations, healthcare agencies, ... read more
From TB to Today – An Evolution of Public Health
The human body is pretty amazing. It can heal itself, adapt to change, and provide mechanisms to rid itself of bad stuff. Of course, there are many instances when the body needs help, and medicines step in to take care of what the body can’t. Our current technologies to fight disease and sickness are truly amazing. I only need to refer you to ... read more
An Interview with Lamin Jallow
The main difference is the level of detail in the new USP 73. As a chapter with a two-digit number, it contains some methodology and details that were missing in the original publication. For instance, it contains an equation to calculate the incubation time before ATP bioluminescence detection is performed. read more
Emerging Roles of Nucleic Acid-Based Methods in Pharmaceutical Microbiology
New technologies based on the detection and sequencing of nucleic acids are emerging rapidly leading to questions about their best applications, validation requirements, limitations, cost, and implementation. Although the focus of this commentary is largely on pharmaceutical microbiology the status of nucleic acid-based methods in environmental, ... read more
Medicine Gets an Upgrade: How AI and ML are Reshaping Medical Practice
Artificial intelligence (AI) research and techniques have been exponentially advancing in recent years, and the application of AI is rapidly transforming the landscape of medicine and bioengineering. Novel AI-based tools are able to extract insights from complex data, augment human capabilities, and improve the accessibility and standardization of ... read more

Executive Q&A: Samsung Biologics
Samsung Biologics continues to introduce new and innovative technology platforms with high-performing solutions that enhance therapeutic efficacy and proactively address evolving industry trends. read more
Whitepaper: Disinfectant Efficacy in cGMP-Compliant Pharmaceutical Manufacturing Settings
The FDA’s intensified onsite inspections of drug production post-pandemic have underscored the importance of robust cleaning- and disinfectant-validation programs. This whitepaper focuses on the importance of disinfectant validations based on real-world conditions to maintain cGMP compliance. It discusses the current lack of ... read more
Container Closure Requirements: Preparing for Updates to USP <382>, <661.1>, and <661.2>
This article will give a comprehensive overview of the evolving container closure requirements for parenteral products and insightful exploration of the alterations introduced by USP <661.1>, <661.2>, and <382>, equipping pharmaceutical manufacturers with the essential knowledge to navigate the evolving regulatory compliance standards effectively.... read more
App Note: To GMP or not to GMP? That is the (PLASMID) question
As drug manufacturers work to secure plasmids for discovery, clinical, and commercial applications, the question looms: how can you maintain a manageable budget while procuring a high- quality plasmid supply? Though opting to begin with a GMP-grade plasmid platform – as opposed to GMP-lite – may initially seem the more ... read more
Clean Labeling in Pharma: Enhancing Transparency and Trust
This article explores the significance of clean labeling in the pharma industry and how it is being utilized to meet consumer expectations. read more

Recent Advances in Crystalline Polymorphism Research in Drug Development
This webinar explores recent advancements in crystal screening and characterization for pharmaceutical development. read more
Speed Meets Precision: Fast Raw Material ID & Advanced Peptide Characterization
As the demand for therapeutic synthetic peptides—such as GLP-1 receptor agonists—continues to surge, biopharmaceutical manufacturers are under increasing pressure to scale production efficiently while maintaining rigorous quality standards. This ... read more
Building Agile Aseptic Operations with Skilled Teams and Smart Tech
The biopharma world is evolving rapidly, driven by rising demand for biologics and advanced therapeutics. To stay ahead, companies are adopting smart technologies and empowering teams to embrace new production methods while meeting strict regulatory ... read more